デフォルト表紙
市場調査レポート
商品コード
1477937

持続グルコースモニタリングシステム市場の予測:~2032年

Continuous Glucose Monitoring System Market Research Report Forecast till 2032

出版日: | 発行: Market Research Future | ページ情報: 英文 152 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
持続グルコースモニタリングシステム市場の予測:~2032年
出版日: 2024年04月30日
発行: Market Research Future
ページ情報: 英文 152 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

持続グルコースモニタリングシステムの市場規模は、予測期間中に11.24%のCAGRで成長すると予測されています。

糖尿病有病率の増加は、世界の持続グルコースモニタリングシステム市場の成長を促進する顕著な要因として際立っています。糖尿病の罹患者数は驚異的な増加を示しており、大流行といえるレベルに達しています。Global Diabetes Alliance (IDF) によると、2021年には世界で約5億3,700万人が糖尿病を患っており、この数は2030年までに6億4,300万人に急増すると予想されています。また、American Diabetes Affiliationによると、2021年には人口の11.6%にあたる3,840万人の米国人が糖尿病に罹患しています。1型糖尿病は、約30万4,000人の子供とティーンエイジャーを含む、およそ200万人の米国人が罹患している。糖尿病人口が増え続けるにつれ、効果的な糖尿病管理ソリューションに対する需要はより切迫したものとなっています。持続グルコースモニタリングシステムは、血糖値をリアルタイムで把握する上で極めて重要な役割を果たし、患者や医療従事者が治療や生活習慣の改善に関して、タイムリーで十分な情報に基づいた意思決定を行うことを可能にします。継続的なモニタリング、異常の早期発見、個別化された洞察を提供する持続型グルコースモニタリングシステムの能力は、拡大する糖尿病人口のニーズに合致しています。

地域別洞察

北米の持続グルコースモニタリングシステム市場は、2023年に30億7,000万米ドルを占め、予測期間中は10.06%のCAGRで成長すると予測されています。

北米の持続グルコースモニタリングシステム市場は、技術的進歩や同地域における糖尿病有病率の上昇に牽引され、力強い成長を遂げています。

欧州の持続グルコースモニタリングシステム市場は、技術の進歩、医療費の増加、糖尿病の有病率の増加により、第2位の市場シェアを占めました。

アジア太平洋の持続グルコースモニタリングシステム市場は、患者数の多さ、臨床試験コストの低さ、有利な規制政策により、2023年から2030年にかけてもっとも急成長すると予測されています。また、主要企業による同地域への積極的な進出も同地域の市場成長を促進しています。

当レポートでは、世界の持続グルコースモニタリングシステムの市場を調査し、市場の定義と概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

  • 促進要因
    • 糖尿病の罹患率の増加
    • 持続グルコースモニタリングと患者教育の利点に関する個人の意識の高まり
    • 高齢化人口の増加
  • 抑制要因
    • 持続グルコースモニタリングシステムの高コスト
  • 機会
    • 技術の進歩と革新の進展

第4章 市場要因分析

  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19が世界の持続グルコースモニタリングシステムに与える影響

第5章 世界の持続グルコースモニタリングシステム市場:製品別

  • 概要
  • センサー
  • トランスミッター&レシーバー

第6章 世界の持続グルコースモニタリングシステム市場:用途別

  • 概要
  • タイプ糖尿病
  • タイプ糖尿病
  • 非糖尿病患者
    • 減量
    • 食事管理
    • ヘルス&ウェルネス

第7章 世界の持続グルコースモニタリングシステム市場:エンドユーザー別

  • 概要
  • 病院・クリニック
  • 在宅ケア
  • その他

第8章 世界の持続グルコースモニタリングシステム市場:地域別

  • 世界
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第9章 競合情勢

  • 市場シェア分析
  • 競合ダッシュボード
  • 公開企業の株式概要
  • 比較分析:主要企業財務
  • 主な展開と成長戦略

第10章 企業プロファイル

  • DEXCOM, INC
  • A. MENARINI DIAGNOSTICS SRL
  • SENSEONICS
  • MEDTRUM TECHNOLOGIES INC.
  • NEMAURA MEDICAL INC
  • ULTRAHUMAN HEALTHCARE PVT LTD
  • MEDTRONIC
  • ONE DROP
  • ABBOTT LABORATORIES, INC
  • SINOCARE
  • NUTRISENSE
  • SUPERSAPIENS
  • SIGNOS INC.
  • LEVELS
  • VERI
  • LUMEN
  • JANUARY.AI

第11章 データ引用

図表

LIST OF TABLES

  • TABLE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTER & RECEIVERS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 4 GLOBAL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 5 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR WEIGHT LOSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIET MANAGEMENT, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET HEALTH & WELLNESS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOMECARE SETTINGS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 15 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 16 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 17 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 18 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 19 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 20 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 21 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 22 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 23 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 24 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 25 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 26 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 27 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 28 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 29 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 30 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 31 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 32 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 33 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 34 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 35 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 36 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 37 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 38 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 39 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 40 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 41 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 42 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 43 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 44 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 45 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 46 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 47 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 48 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 49 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 50 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 51 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 52 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 53 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 54 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 55 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 56 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 57 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 58 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 59 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 60 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 61 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 62 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 63 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 64 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 65 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 66 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 67 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 68 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 69 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 70 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 71 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 72 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 73 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 74 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 75 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 76 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 77 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 78 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 79 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 80 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 81 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 82 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 83 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 84 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 85 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 86 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 87 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 88 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 89 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 90 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 91 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 92 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 93 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 94 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 95 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 96 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 97 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 98 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 99 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 100 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 101 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 102 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 103 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 104 AGREEMENT
  • TABLE 105 PERTNERSHIP
  • TABLE 106 COLLABORATION
  • TABLE 107 DEXCOM, INC: PRODUCT OFFERED
  • TABLE 108 DEXCOM, INC: KEY DEVELOPMENTS
  • TABLE 109 A. MENARINI DIAGNOSTICS SRL: PRODUCT OFFERED
  • TABLE 110 A. MENARINI DIAGNOSTICS SRL: KEY DEVELOPMENTS
  • TABLE 111 SENSEONICS: PRODUCT OFFERED
  • TABLE 112 SENSEONICS: KEY DEVELOPMENTS
  • TABLE 113 MEDTRUM TECHNOLOGIES INC.: PRODUCTS OFFERED
  • TABLE 114 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 115 NEMAURA MEDICAL INC.: KEY DEVELOPMENTS
  • TABLE 116 ULTRAHUMAN HEALTHCARE PVT LTD.: PRODCUTS OFFERED
  • TABLE 117 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 118 MEDTRONIC: KEY DEVELOPMENTS
  • TABLE 119 ONE DROP: PRODUCTS OFFERED
  • TABLE 120 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 121 ABBOTT LABORATORIES, INC.: KEY DEVELOPMENTS
  • TABLE 122 SINOCARE: PRODUCTS OFFERED
  • TABLE 123 NUTRISENSE: PRODUCTS OFFERED
  • TABLE 124 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 125 SIGNOS INC.: PRODUCTS OFFERED
  • TABLE 126 LEVELS: PRODUCTS OFFERED
  • TABLE 127 VERI: PRODUCTS OFFERED
  • TABLE 128 LUMEN: PRODUCTS OFFERED
  • TABLE 129 JANUARY.AI: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: STRUCTURE
  • FIGURE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY PRODUCT,
  • FIGURE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY APPLICATION,
  • FIGURE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY END USER,
  • FIGURE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY REGION, 2023 (% SHARE)
  • FIGURE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 15 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
  • FIGURE 16 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 17 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
  • FIGURE 18 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 19 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 20 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 21 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 22 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY REGION,
  • FIGURE 23 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET PLAYERS: COMPETITIVE ANALSIS,
  • FIGURE 24 COMPETITOR DASHBOARD: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 25 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 26 DEXCOM, INC: SWOT ANALYSIS
  • FIGURE 27 SENSEONICS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 NEMAURA MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 NEMAURA MEDICAL INC.: SWOT ANALYSIS
  • FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 31 MEDTRONIC: SWOT ANALYSIS
  • FIGURE 32 ONE DROP: SWOT ANALYSIS
  • FIGURE 33 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 34 ABBOTT LABORATORIES INC.: SWOT ANALYSIS
目次
Product Code: MRFR/HC/18762-CR

Download PDF

Market Overview

Continuous Glucose Monitoring System Market is projected to register a CAGR of 11.24% during the review period.

The rising pervasiveness of diabetes overall stands apart as a conspicuous driver energizing the development of the worldwide continuous glucose monitoring systems market. Diabetes has arrived at plague extents, with a stunning ascent in the quantity of impacted people universally. As per the Global Diabetes Alliance (IDF), in 2021, roughly 537 million individuals overall were living with diabetes, and this number is supposed to take off to 643 million by 2030. Essentially, as per the American Diabetes Affiliation, diabetes impacted 38.4 million Americans, or 11.6% of the populace, in 2021. Type 1 diabetes influences around 2.0 million Americans, including roughly 304,000 youngsters and teenagers. The heightening rate of diabetes is ascribed to different elements, including stationary ways of life, unfortunate dietary propensities, and the maturing populace. As the diabetic populace keeps on developing, the interest for powerful diabetes the board arrangements turn out to be really squeezing. Continuous glucose monitoring systems assume a vital part in giving constant experiences into blood glucose levels, empowering patients and medical care experts to settle on convenient and informed choices in regard to therapy and way of life changes. The capacity of continuous glucose monitoring systems to offer continuous monitoring, early discovery of variances, and customized bits of knowledge lines up with the developing requirements of the extending diabetic populace.

Market Segmentation

Based on product the continuous glucose monitoring system market is divided into sensors and transmitter and receivers.

In terms of application, the market is classified into type 2 diabetes, type 1 diabetes, and non-diabetic patients.

Based on End user, the market has been divided into hospitals & clinics, homecare settings, and others.

Regional Insights

The North America continuous glucose monitoring systems market represented USD 3.07 billion out of 2023 and is projected to develop at a CAGR of 10.06% during the figure time frame. North America is additionally fragmented into the US, and Canada.

The North America continuous glucose monitoring systems market is encountering strong development, driven by mechanical progressions and a rising predominance of diabetes in the region.

Europe continuous glucose monitoring System market represented the second-biggest market share because of innovation progressions, expanding medical care consumption, and expanding pervasiveness of diabetes.

The Asia-Pacific Continuous Glucose Monitoring System market is supposed to be the quickest developing from 2023 to 2030 attributable to high persistent populace, decreased expenses of leading preliminaries, and good administrative arrangements. In addition, central participants working in the Continuous Glucose Monitoring System Market are effectively venturing into this region, further driving the regional market development.

Major Players

Key Companies operating in the Continuous Glucose Monitoring System market are Dexcom, Inc (US), Menarini Diagnostics Srl (Italy), Senseonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc (US), Ultrahuman Healthcare Pvt Ltd (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), and Sinocare (China).

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 DEFINITION
  • 1.2 SCOPE OF THE STUDY
  • 1.3 RESEARCH OBJECTIVE
  • 1.4 MARKET STRUCTURE

2 RESEARCH METHODOLOGY

  • 2.1 OVERVIEW
  • 2.2 DATA FLOW
    • 2.2.1 DATA MINING PROCESS
  • 2.3 PURCHASED DATABASE
  • 2.4 SECONDARY SOURCES
    • 2.4.1 SECONDARY RESEARCH DATA FLOW:
  • 2.5 PRIMARY RESEARCH:
    • 2.5.1 PRIMARY RESEARCH DATA FLOW:
    • 2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 2.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 2.6.1 REVENUE ANALYSIS APPROACH
  • 2.7 DATA FORECASTING
    • 2.7.1 DATA FORECASTING TECHNIQUE
  • 2.8 DATA MODELING
    • 2.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 2.8.2 DATA MODELING:
  • 2.9 TEAMS AND ANALYST CONTRIBUTION

3 MARKET DYNAMICS

  • 3.1 INTRODUCTION
  • 3.2 DRIVERS
    • 3.2.1 INCREASING PREVALENCE OF DIABETES
    • 3.2.2 RISING AWARENESS AMONG INDIVIDUALS ABOUT THE BENEFITS OF CONTINUOUS GLUCOSE MONITORING AND PATIENT EDUCATION
    • 3.2.3 INCREASING GERIATRIC POPULATION
  • 3.3 RESTRAINTS
    • 3.3.1 HIGH COST OF CONTINUOUS GLUCOSE MONITORING SYSTEMS
  • 3.4 OPPORTUNITY
    • 3.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION

4 MARKET FACTOR ANALYSIS

  • 4.1 VALUE CHAIN ANALYSIS
    • 4.1.1 R&D
    • 4.1.2 MANUFACTURING
    • 4.1.3 DISTRIBUTION AND SALES
    • 4.1.4 POST-SALES MONITORING
  • 4.2 PORTER'S FIVE FORCES MODEL
    • 4.2.1 THREAT OF NEW ENTRANTS
    • 4.2.2 BARGAINING POWER OF SUPPLIERS
    • 4.2.3 THREAT OF SUBSTITUTES
    • 4.2.4 BARGAINING POWER OF BUYERS
    • 4.2.5 INTENSITY OF RIVALRY
  • 4.3 IMPACT OF COVID-19 ON THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS

MARKET

    • 4.3.1 OVERVIEW

5 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

  • 5.1 OVERVIEW
  • 5.2 SENSORS
  • 5.3 TRANSMITTER & RECEIVERS

6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

  • 6.1 OVERVIEW
  • 6.2 TYPE DIABETES
  • 6.3 TYPE DIABETES
  • 6.4 NON-DIABETIC PATIENTS
    • 6.4.1 WEIGHT LOSS
    • 6.4.2 DIET MANAGEMENT
    • 6.4.3 HEALTH & WELLNESS

7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 HOSPITALS & CLINICS
  • 7.3 HOMECARE SETTINGS
  • 7.4 OTHERS

8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

  • 8.1 GLOBAL
  • 8.2 NORTH AMERICA
    • 8.2.1 US
    • 8.2.2 CANADA
  • 8.3 EUROPE
    • 8.3.1 GERMANY
    • 8.3.2 FRANCE
    • 8.3.3 UK
    • 8.3.4 ITALY
    • 8.3.5 SPAIN
    • 8.3.6 REST OF EUROPE
  • 8.4 ASIA-PACIFIC
    • 8.4.1 CHINA
    • 8.4.2 INDIA
    • 8.4.3 JAPAN
    • 8.4.4 SOUTH KOREA
    • 8.4.5 AUSTRALIA
    • 8.4.6 REST OF ASIA-PACIFIC
  • 8.5 REST OF THE WORLD
    • 8.5.1 MIDDLE EAST & AFRICA
    • 8.5.2 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 MARKET SHARE ANALYSIS,
  • 9.3 COMPETITOR DASHBOARD
  • 9.4 PUBLIC PLAYERS STOCK SUMMARY
  • 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
    • 9.6.2 AGREEMENT
    • 9.6.3 PARTNERSHIP
    • 9.6.4 COLLABORATION

10 COMPANY PROFILES

  • 10.1 DEXCOM, INC
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL OVERVIEW
    • 10.1.3 PRODUCTS OFFERED
    • 10.1.4 KEY DEVELOPMENTS
    • 10.1.5 SWOT ANALYSIS
    • 10.1.6 KEY STRATEGIES
  • 10.2 A. MENARINI DIAGNOSTICS SRL
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL OVERVIEW
    • 10.2.3 PRODUCTS OFFERED
    • 10.2.4 KEY DEVELOPMENTS
    • 10.2.5 KEY STRATEGIES
  • 10.3 SENSEONICS
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 FINANCIAL OVERVIEW
    • 10.3.3 PRODUCTS OFFERED
    • 10.3.4 KEY DEVELOPMENTS
    • 10.3.5 KEY STRATEGIES
  • 10.4 MEDTRUM TECHNOLOGIES INC.
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL OVERVIEW
    • 10.4.3 PRODUCTS OFFERED
    • 10.4.4 KEY DEVELOPMENTS
    • 10.4.5 KEY STRATEGIES
  • 10.5 NEMAURA MEDICAL INC
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL OVERVIEW
    • 10.5.3 PRODUCTS OFFERED
    • 10.5.4 KEY DEVELOPMENTS
    • 10.5.5 SWOT ANALYSIS
    • 10.5.6 KEY STRATEGIES
  • 10.6 ULTRAHUMAN HEALTHCARE PVT LTD
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL OVERVIEW
    • 10.6.3 PRODUCTS OFFERED
    • 10.6.4 KEY DEVELOPMENTS
    • 10.6.5 KEY STRATEGIES
  • 10.7 MEDTRONIC
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL OVERVIEW
    • 10.7.3 PRODUCTS OFFERED
    • 10.7.4 KEY DEVELOPMENTS
    • 10.7.5 SWOT ANALYSIS
    • 10.7.6 KEY STRATEGIES
  • 10.8 ONE DROP
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 FINANCIAL OVERVIEW
    • 10.8.3 PRODUCTS OFFERED
    • 10.8.4 KEY DEVELOPMENTS
    • 10.8.5 SWOT ANALYSIS
    • 10.8.6 KEY STRATEGIES
  • 10.9 ABBOTT LABORATORIES, INC
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL OVERVIEW
    • 10.9.3 PRODUCTS OFFERED
    • 10.9.4 KEY DEVELOPMENTS
    • 10.9.5 SWOT ANALYSIS
    • 10.9.6 KEY STRATEGIES
  • 10.10 SINOCARE
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL OVERVIEW
    • 10.10.3 PRODUCTS OFFERED
    • 10.10.4 KEY DEVELOPMENTS
    • 10.10.5 KEY STRATEGIES
  • 10.11 NUTRISENSE
    • 10.11.1 COMPANY OVERVIEW
    • 10.11.2 FINANCIAL OVERVIEW
    • 10.11.3 PRODUCTS OFFERED
    • 10.11.4 KEY DEVELOPMENTS
    • 10.11.5 KEY STRATEGIES
  • 10.12 SUPERSAPIENS
    • 10.12.1 COMPANY OVERVIEW
    • 10.12.2 FINANCIAL OVERVIEW
    • 10.12.3 PRODUCTS OFFERED
    • 10.12.4 KEY DEVELOPMENTS
    • 10.12.5 KEY STRATEGIES
  • 10.13 SIGNOS INC.
    • 10.13.1 COMPANY OVERVIEW
    • 10.13.2 FINANCIAL OVERVIEW
    • 10.13.3 PRODUCTS OFFERED
    • 10.13.4 KEY DEVELOPMENTS
    • 10.13.5 KEY STRATEGIES
  • 10.14 LEVELS
    • 10.14.1 COMPANY OVERVIEW
    • 10.14.2 FINANCIAL OVERVIEW
    • 10.14.3 PRODUCTS OFFERED
    • 10.14.4 KEY DEVELOPMENTS
    • 10.14.5 KEY STRATEGIES
  • 10.15 VERI
    • 10.15.1 COMPANY OVERVIEW
    • 10.15.2 FINANCIAL OVERVIEW
    • 10.15.3 PRODUCTS OFFERED
    • 10.15.4 KEY DEVELOPMENTS
    • 10.15.5 KEY STRATEGIES
  • 10.16 LUMEN
    • 10.16.1 COMPANY OVERVIEW
    • 10.16.2 FINANCIAL OVERVIEW
    • 10.16.3 PRODUCTS OFFERED
    • 10.16.4 KEY DEVELOPMENTS
    • 10.16.5 KEY STRATEGIES
  • 10.17 JANUARY.AI
    • 10.17.1 COMPANY OVERVIEW
    • 10.17.2 FINANCIAL OVERVIEW
    • 10.17.3 PRODUCTS OFFERED
    • 10.17.4 KEY DEVELOPMENTS
    • 10.17.5 KEY STRATEGIES

11 DATA CITATIONS